Skip to main content

Table 3 Prevalence and pattern of abnormalities of smell/taste

From: Prevalence and outcomes of olfactory and gustatory dysfunctions in hospitalized SARS-CoV-2-infected patients

Variable

Count

Valid %

Prevalence of specific forms of smell/taste abnormality

 Nil

286

49.4%

 Total smell loss

9

1.6%

 Total taste loss

60

10.4%

 Total smell and taste loss

140

24.2%

 Partial smell loss

16

2.8%

 Partial taste loss

18

3.1%

 Partial smell and taste loss

50

8.6%

The overall prevalence of smell/taste abnormality

 No smell/taste abnormality

286

49.4%

 Smell/taste abnormality of any form

293

50.6%

The onset of anosmia/dysgeusia to the diagnosis of COVID-19

 Before diagnosis of COVID-19

164

56.0%

 After diagnosis of COVID-19

129

44.0%

Other symptoms before the development of anosmia/dysgeusia

 No other symptoms before the development of anosmia/dysgeusia

69

23.5%

 Other symptoms present before the development of anosmia/dysgeusia

224

76.5%

The onset of anosmia/dysgeusia

 Gradual

103

35.2%

 Sudden

190

64.8%